Muscular Dystrophy Canada is dedicated to excellence in all aspects of scientific research, including basic, focused, and applied work. We firmly believe that the best way to find a cure for neuromuscular disorders is through collaboration, innovative research, and a rigorous adherence to scientific principles. For more information about these projects, please read our publication Research in the Works 2012-13.
Muscular Dystrophy Canada believes in the importance of partnership. From 2000 to 2012, Muscular Dystrophy Canada partnered with the ALS Society of Canada and the Canadian Institutes of Health Research (Institute of Musculoskeletal Health and Arthritis, Institute of Genetics, and the Institute of Neurosciences, Mental Health and Addiction) to sponsor the Neuromuscular Research Partnership (NRP). The goal of the NRP was to fund excellence in basic, focused or applied research that would move us closer towards treatment options, and ultimately a cure, for neuromuscular disorders.
In the final year of the Partnership (2012), 13 new grants were awarded, with a cumulative value of $7,557,749.
Since its inception, the partners invested over $43 million into 177 Canadian research projects. While the researchers investigate a range of approaches and targets, they share in a common goal –increasing our understanding of neuromuscular disorders, in order to develop better treatments and ultimately a cure. Below are selected profiles that highlight the progress and hope for the future.
Research in the Works
Our Research in the Works publication contains more detailed information about the research that we fund.